6-(3-(4-(benzhydryloxy)piperidin-1-yl)propoxy)-[1,2,4]triazolo[4,3-b]pyridazine

ID: ALA5199759

PubChem CID: 15524155

Max Phase: Preclinical

Molecular Formula: C26H29N5O2

Molecular Weight: 443.55

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  c1ccc(C(OC2CCN(CCCOc3ccc4nncn4n3)CC2)c2ccccc2)cc1

Standard InChI:  InChI=1S/C26H29N5O2/c1-3-8-21(9-4-1)26(22-10-5-2-6-11-22)33-23-14-17-30(18-15-23)16-7-19-32-25-13-12-24-28-27-20-31(24)29-25/h1-6,8-13,20,23,26H,7,14-19H2

Standard InChI Key:  DUSWWKGTWIFTNE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   -2.0630    0.4116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3486    0.8241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6341    0.4116    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6341   -0.4134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3486   -0.8259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0630   -0.4134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7773   -0.8258    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4916   -0.4134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2058   -0.8258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4916    0.4113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2057    0.8239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2050    1.6462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4905    2.0587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7790    1.6496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7743    0.8254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2061   -1.6506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9186   -2.0610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6330   -1.6486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6346   -0.8279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9231   -0.4116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0801    0.8240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7942    0.4116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5085    0.8240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2228    0.4116    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9371    0.8240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9371    1.6487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6512    2.0610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3656    1.6486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3656    0.8239    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6512    0.4116    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1498    0.5691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1499    1.9034    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6346    1.2362    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  0
  4  3  1  0
  5  4  1  0
  1  6  1  0
  6  5  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 11 10  2  0
 12 11  1  0
 13 12  2  0
 14 13  1  0
 15 14  2  0
 10 15  1  0
 16  9  2  0
 17 16  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
  9 20  1  0
  3 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 26 25  1  0
 27 26  2  0
 28 27  1  0
 29 28  1  0
 30 29  1  0
 25 30  2  0
 29 31  1  0
 28 32  2  0
 32 33  1  0
 33 31  2  0
M  END

Associated Targets(Human)

PARP14 Tchem Poly [ADP-ribose] polymerase 14 (380 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 443.55Molecular Weight (Monoisotopic): 443.2321AlogP: 4.16#Rotatable Bonds: 9
Polar Surface Area: 64.78Molecular Species: BASEHBA: 7HBD:
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.61CX LogP: 3.68CX LogD: 2.44
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.36Np Likeness Score: -1.49

References

1. Nizi MG, Maksimainen MM, Lehtiö L, Tabarrini O..  (2022)  Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules.,  65  (11.0): [PMID:35608571] [10.1021/acs.jmedchem.2c00281]

Source